Neuroscience金沙官网8331澳门

金沙官网手机下载app

金沙官网手机下载app

With a rich heritage and a research and development focus on specific aspects of neurodegenerative diseases, analgesia and psychiatry, AstraZeneca continues to push the boundaries of science in neuroscience in collaboration with other innovative partners across industry and academia. A significant unmet medical need remains in the areas of cognitive disorders, chronic pain and other central nervous system disorders. 

 

金沙官网手机下载app

More than 450 million people worldwide are affected by mental, neurological or behavioural problems, and the number is steadily rising.

  • 金沙官网8331澳门

    AD is a fatal illness that causes progressive decline in memory and other aspects of cognition.


    金沙官网
  • 金沙官网8331澳门

    OIC is a condition caused by prescription opioid pain medicines. Millions of patients are treated with opioids each year.


    金沙登录平台入口

金沙官网手机下载app

We are committed to developing novel therapies that advance the science of neurodegenerative diseases and have the potential to provide a positive impact on patients around the world.

        Image: Artistic rendering of BACE enzyme.

金沙官网手机下载app

Partnering with influential organisations to extend the reach of our science to more patients and healthcare providers


金沙官网手机下载app

Our approach in Neuroscience looks to maximise revenue through externalisation and on-market products; advance the novel product pipeline with partnerships where appropriate; and preserve a company stake in the most promising assets.


Our pipeline金沙官网8331澳门

金沙官网手机下载app

金沙官网手机下载app

We cannot provide detailed information about our prescription medicines on this website, in compliance with regulations. Our medicines are approved in individual countries for specific uses and the information we provide for patients is governed by local regulations. In some cases, health care professionals and patients can visit local AstraZeneca websites to find out more about our medicines. Please note that in some countries we are not allowed to provide very much, or sometimes any, information on our prescription medicines so you should seek alternative trustworthy sources. Always ask a healthcare professional for advice about medicines.

Diprivan金沙官网8331澳门

propofol

EMLA金沙官网8331澳门

EMLA

Movantik/Moventig 金沙官网8331澳门

naloxegol

Naropin金沙官网8331澳门

ropivacaine

Seroquel IR金沙官网8331澳门

quetiapine fumarate

Seroquel XR金沙官网8331澳门

quetiapine fumarate

Xylocaine金沙官网8331澳门

lidocaine

Zomig, Zomig Rapimelt, Zomig Nasal Spray, AscoTop, Zomigon 金沙官网8331澳门

zolmitriptan

金沙官网手机下载app



金沙官网手机下载app

and help us deliver life-changing medicines

Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.


Veeva ID: Z4-17491    

Date of next review: 07/06/2021